SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001385508-18-000037
Filing Date
2018-05-08
Accepted
2018-05-08 16:07:47
Documents
61
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q opnt0331201810q.htm 10-Q 589570
2 EXHIBIT 31.1 exhibit31103312018.htm EX-31.1 12649
3 EXHIBIT 31.2 exhibit31203312018.htm EX-31.2 12628
4 EXHIBIT 32.1 exhibit32103312018.htm EX-32.1 5807
5 EXHIBIT 32.2 exhibit32203312018.htm EX-32.2 5569
  Complete submission text file 0001385508-18-000037.txt   4127697

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT opnt-20180331.xml EX-101.INS 608378
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20180331.xsd EX-101.SCH 52414
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opnt-20180331_cal.xml EX-101.CAL 45444
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20180331_def.xml EX-101.DEF 262775
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20180331_lab.xml EX-101.LAB 553734
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20180331_pre.xml EX-101.PRE 362385
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38193 | Film No.: 18814575
SIC: 1000 Metal Mining